ARCHIVES

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

This article is from The Cancer Letter archive.

Vol. 28 No. 13 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

USC, Wisconsin Get Construction Grants Totaling $1.5 Million

March 23, 1990

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

NCI advisory Group, Other Cancer Meetings

March 29, 1985

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Copeland Named Director, UF Cancer Center

February 10, 1995